AAO 2020: Medication could reduce burden of steroid drops for patients

Cynthia Matossian, MD, FACES, ABES, of Matossian Eye Associates, presents the highlights of a poster on outcomes with dexamethasone intraocular suspension 9% and concomitant postoperative anti-inflammatory medications.

The study examined early experiences among cataract surgeons with the use of the injectabcle ophthalmic anti-inflammatory medications.